Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98429 | 1.00 | NAAA (0.47) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL97896 | 1.00 | NAAA (0.47) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL1756096 | 1.00 | NAAA (0.47) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL98110 | 0.98 | NAAA (0.43) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL607473 | 0.93 | NAAA (0.39) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL16536415 | 0.92 | NAAA (0.60) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL16536983 | 0.92 | NAAA (0.60) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL3725725 | 0.92 | NAAA (0.60) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL5898808 | 0.92 | NAAA (0.60) | NAAANPSR1RAD52FAAHMAPT | |
| SCHEMBL11406622 | 0.92 | NAAA (0.60) | NAAANPSR1RAD52FAAHMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4703778-A1 | WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE | Dai Nippon Printing Co., Ltd. (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | FUJIFILM CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4202505-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM | DAINIPPON PRINTING CO LTD (JP) | 2026-02-18 | — | — | EP | disclosed |
| EP-4201667-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE WHICH USE SAME | DAINIPPON PRINTING CO LTD (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-12496802-B2 | Barrier film, wavelength conversion sheet using same, backlight and liquid crystal display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2025-12-16 | — | — | US | disclosed |
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| EP-4202506-B1 | BARRIER FILM, WAVELENGTH CONVERSION SHEET USING SAME, BACKLIGHT AND LIQUID CRYSTAL DISPLAY DEVICE | DAINIPPON PRINTING CO LTD (JP) | 2025-11-26 | — | — | EP | disclosed |
| EP-4579289-A1 | WAVELENGTH CONVERSION SHEET, AND BACKLIGHT AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME | Dai Nippon Printing Co., Ltd. (JP) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025084339-A1 | METHOD FOR MANUFACTURING WAVELENGTH CONVERSION SHEET | 大日本印刷株式会社 | 2025-04-24 | — | — | WO | disclosed |
| US-20070021571-A1 | Curable polymer compound | SHOWA DENKO K.K. (JP) | 2007-01-25 | — | — | US | disclosed |
| EP-1682589-A1 | CURABLE POLYMER COMPOUND | Showa Denko K.K. (JP) | 2006-07-26 | — | — | EP | disclosed |
| US-20060041053-A1 | Color filter black matrix resist composition and carbon black dispersion composition used for the composition | SHOWA DENKO K.K. (JP) | 2006-02-23 | — | — | US | disclosed |
| US-20060036023-A1 | Color filter black matrix resist composition | SHOWA DENKO K.K. (JP) | 2006-02-16 | — | — | US | disclosed |
| US-20050258406-A1 | Black resist composition for color filter | SHOWA DENKO K.K. | 2005-11-24 | — | — | US | disclosed |
| EP-1576418-A1 | COLOR FILTER BLACK MATRIX RESIST COMPOSITION AND CARBON BLACK DISPERSION COMPOSITION USED FOR THE COMPOSITION | Showa Denko K.K. (JP) | 2005-09-21 | — | — | EP | disclosed |
| EP-1573397-A1 | COLOR FILTER BLACK MATRIX RESIST COMPOSITION | Showa Denko K.K. (JP) | 2005-09-14 | — | — | EP | disclosed |
| WO-2005047346-A1 | CURABLE POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-05-26 | — | — | WO | disclosed |
| WO-2004055597-A1 | COLOR FILTER BLACK MATRIX RESIST COMPOSITION AND CARBON BLACK DISPERSION COMPOSITION USED FOR THE COMPOSITION | SHOWA DENKO K. K. (JP) | 2004-07-01 | — | — | WO | disclosed |
| WO-2004055596-A1 | COLOR FILTER BLACK MATRIX RESIST COMPOSITION | SHOWA DENKO K. K. (JP) | 2004-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | NLRP1, NLRP3, ALAD | NAAA 4821/4885NPSR1 4827/4885RAD52 2837/4885 |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | SEM1, PSMA1, RER1 | NAAA 3391/4885NPSR1 2014/4885RAD52 2036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.